Drug intelligence / Profile preview

propranolol + sertraline

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

Propranolol + sertraline is a combination of two small molecule drugs, each with distinct mechanisms of action and therapeutic uses. Propranolol is a non-selective beta-adrenergic receptor antagonist (beta blocker) primarily used to treat hypertension, angina, arrhythmias, migraine prophylaxis, and the physical symptoms of anxiety. Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant indicated for major depressive disorder, social anxiety disorder, panic disorder, and other psychiatric conditions. When used together—though not available as a fixed-dose combination product—they may be co-prescribed to address both the psychological (sertraline) and physical (propranolol) symptoms of anxiety or related disorders. Caution is advised due to potential pharmacokinetic interactions; sertraline can increase serum concentrations of propranolol by inhibiting its metabolism[1][2][5]. This may enhance propranolol’s effects or side effects such as bradycardia or hypotension.

02

Targets

SERT (Sodium-dependent serotonin transporter)ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on propranolol + sertraline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propranolol + sertraline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call